10x Genomics, Inc.
TXG
$61.65
$1.672.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -151.92% | 60.80% | 66.85% | 23.16% | 191.14% |
| Total Depreciation and Amortization | 23.66% | 24.12% | 14.54% | 13.96% | -28.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.87% | -24.88% | -20.37% | -20.76% | -24.67% |
| Change in Net Operating Assets | 92.44% | -81.30% | 1,450.15% | 144.54% | -1,220.76% |
| Cash from Operations | -4.15% | -23.96% | 704.28% | 99.69% | 136.23% |
| Capital Expenditure | -0.63% | 15.64% | 34.57% | 82.33% | 45.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -107.20% | -- | 101.28% | 85.24% | -95.69% |
| Cash from Investing | -723.75% | 30.74% | 96.50% | -143.26% | -107.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -14.37% | -35.31% | -50.37% | 295.51% | -23.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.37% | -2,094.55% | -50.37% | 295.51% | -23.48% |
| Foreign Exchange rate Adjustments | -107.78% | -164.04% | 115.99% | -121.15% | 12,100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.79% | -50.54% | 176.27% | 90.88% | -14.11% |